Sunday, January 05, 2025 | 12:08 PM ISTEN Hindi

Home / Companies / News / US books 100 mn Covid-19 vaccine doses for $2.1 bn from GSK, Sanofi Pasteur

US books 100 mn Covid-19 vaccine doses for $2.1 bn from GSK, Sanofi Pasteur

The US government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed programme

covid, coronavirus, vaccine, drug, pharma

Premium

Earlier this week the British government signed a deal for 60 million doses of a potential coronavirus vaccine that could start to be rolled out in the first half of next year.

AP | PTI London

2 min read Last Updated : Jul 31 2020 | 7:45 PM IST

Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental Covid-19 vaccine to the United States as governments buy up supplies in hopes something will work.

The United States will pay up to $2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of its vaccine,'' the companies said in a statement. Sanofi will get the bulk of the funds.

The US government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed programme.

The portfolio of vaccines being assembled

Topics : Sanofi Pasteur GlaxoSmithKline Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in